|
|
Changes in plasma levels of n-arachidonoyl ethanolamine and N-palmitoylethanolamine following bariatric surgery in morbidly obese females with impaired glucose homeostasis
|
|
|
|
|
نویسنده
|
mallipedhi a. ,prior s.l. ,dunseath g. ,bracken r.m. ,barry j. ,caplin s. ,eyre n. ,morgan j. ,baxter j.n. ,o'sullivan s.e. ,sarmad s. ,barrett d.a. ,bain s.c. ,luzio s.d. ,stephens j.w.
|
منبع
|
journal of diabetes research - 2015 - دوره : 2015 - شماره : 0
|
چکیده
|
Aim. we examined endocannabinoids (ecs) in relation to bariatric surgery and the association between plasma ecs and markers of insulin resistance. methods. a study of 20 participants undergoing bariatric surgery. fasting and 2-hour plasma glucose,lipids,insulin,and c-peptide were recorded preoperatively and 6 months postoperatively with plasma ecs (aea,2-ag) and endocannabinoid-related lipids (pea,oea). results. gender-specific analysis showed differences in aea,oea,and pea preoperatively with reductions in aea and pea in females postoperatively. preoperatively,aea was correlated with 2-hour glucose (r=0.55,p=0.01),homa-ir (r=0.61,p=0.009),and homa %s (r=-0.71,p=0.002). oea was correlated with weight (r=0.49,p=0.03),waist circumference (r=0.52,p=0.02),fasting insulin (r=0.49,p=0.04),and homa-ir (r=0.48,p=0.05). pea was correlated with fasting insulin (r=0.49,p=0.04). 2-ag had a negative correlation with fasting glucose (r=-0.59,p=0.04). conclusion. gender differences exist in circulating ecs in obese subjects. females show changes in aea and pea after bariatric surgery. specific correlations exist between different ecs and markers of obesity and insulin and glucose homeostasis. © 2015 akhila mallipedhi et al.
|
|
|
آدرس
|
diabetes research group,institute of life sciences,swansea university,swansea,united kingdom,department of diabetes and endocrinology,morriston hospital,abm university health board, United Kingdom, diabetes research group,institute of life sciences,swansea university, United Kingdom, diabetes research group,institute of life sciences,swansea university, United Kingdom, diabetes research group,institute of life sciences,swansea university, United Kingdom, welsh institute of metabolic and obesity surgery,morriston hospital,abm university health board, United Kingdom, welsh institute of metabolic and obesity surgery,morriston hospital,abm university health board, United Kingdom, welsh institute of metabolic and obesity surgery,morriston hospital,abm university health board, United Kingdom, welsh institute of metabolic and obesity surgery,morriston hospital,abm university health board, United Kingdom, welsh institute of metabolic and obesity surgery,morriston hospital,abm university health board, United Kingdom, division of medical sciences and graduate entry medicine,university of nottingham,royal derby hospital, United Kingdom, centre for analytical bioscience,school of pharmacy,university of nottingham, United Kingdom, centre for analytical bioscience,school of pharmacy,university of nottingham, United Kingdom, diabetes research group,institute of life sciences,swansea university, United Kingdom, diabetes research group,institute of life sciences,swansea university, United Kingdom, diabetes research group,institute of life sciences,swansea university,swansea,united kingdom,department of diabetes and endocrinology,morriston hospital,abm university health board,swansea,united kingdom,welsh institute of metabolic and obesity surgery,morriston hospital,abm university health board, United Kingdom
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Authors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|